Astera Labs, Inc. (NASDAQ:ALAB – Free Report) – Analysts at Northland Capmk issued their Q1 2024 EPS estimates for shares of Astera Labs in a report issued on Thursday, April 18th. Northland Capmk analyst G. Richard anticipates that the company will post earnings of ($0.16) per share for the quarter. Northland Capmk also issued estimates for Astera Labs’ Q2 2024 earnings at ($0.18) EPS, Q3 2024 earnings at ($0.16) EPS, Q4 2024 earnings at ($0.10) EPS, FY2024 earnings at ($0.65) EPS, Q1 2025 earnings at ($0.13) EPS, Q2 2025 earnings at ($0.10) EPS, Q3 2025 earnings at ($0.10) EPS, Q4 2025 earnings at ($0.09) EPS and FY2025 earnings at ($0.41) EPS.
Other equities analysts have also recently issued reports about the stock. Stifel Nicolaus started coverage on shares of Astera Labs in a research report on Monday, April 15th. They set a “buy” rating and a $81.00 price objective for the company. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Astera Labs in a report on Monday, April 15th. They set a “buy” rating and a $85.00 target price for the company. Craig Hallum initiated coverage on shares of Astera Labs in a report on Monday, April 15th. They set a “buy” rating and a $90.00 target price for the company. JPMorgan Chase & Co. initiated coverage on shares of Astera Labs in a report on Monday, April 15th. They set an “overweight” rating and a $85.00 target price for the company. Finally, Roth Mkm initiated coverage on shares of Astera Labs in a report on Monday, April 15th. They set a “buy” rating and a $85.00 target price for the company. Eleven analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $86.09.
Astera Labs Stock Up 9.0 %
NASDAQ:ALAB opened at $71.72 on Monday. Astera Labs has a fifty-two week low of $50.61 and a fifty-two week high of $95.21.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Astera Labs stock. Seven Grand Managers LLC purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 50,000 shares of the company’s stock, valued at approximately $3,710,000. Astera Labs makes up approximately 1.8% of Seven Grand Managers LLC’s investment portfolio, making the stock its 23rd biggest position.
Insider Activity at Astera Labs
In related news, Director Jack R. Lazar bought 10,000 shares of the stock in a transaction on Friday, March 22nd. The stock was bought at an average price of $36.00 per share, with a total value of $360,000.00. Following the completion of the purchase, the director now directly owns 165,000 shares in the company, valued at approximately $5,940,000. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Further Reading
- Five stocks we like better than Astera Labs
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Charles Schwab Fortifies its Uptrend on EPS Beat
- The How and Why of Investing in Biotech Stocks
- Lockheed Martin Stock Aims for a Fresh All-Time High
- What is the Australian Securities Exchange (ASX)
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.